THE 2-MINUTE RULE FOR SITUS JUDI MBL77

Not all individuals with CLL call for therapy. Despite all new advancements, the iwCLL nevertheless recommends watchful observation for sufferers with asymptomatic disorder.86 This suggestion relies on at the least two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).MPO7